Gerald D. Cagle's most recent trade in CalciMedica Inc was a trade of 3,322 Series B Preferred Stock done . Disclosure was reported to the exchange on Sept. 29, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CalciMedica Inc | Gerald D. Cagle | Director | 29 Sep 2020 | 3,322 | 0 | - | - | Series B Preferred Stock | ||
| CalciMedica Inc | Gerald D. Cagle | Director | 29 Sep 2020 | 3,322 | 3,322 | - | - | Common Stock | ||
| CalciMedica Inc | Gerald D. Cagle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 25,000 | 25,000 | - | - | Director Stock Option (Right to Buy) |